INS and osteomyelitis: ROR, IC025, and q-ROR tendencies of the canagliflozin–osteomyelitis pair were significantly different from those generated by the insulin–osteomyelitis pair, and there was no positive signal for hypoglycemic drugs paired with osteomyelitis other than canagliflozin and insulin.